K. König

T. Zander, M. Odenthal, Y. Ko, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Four-and-a-Half LIM Domain Protein 2 Is a Novel Regulator of Sphingosine 1-Phosphate Receptor 1 in CCL19-Induced Dendritic Cell Migration

R. Buettner, P. Knolle, W. Kolanus, 2010, The Journal of Immunology.

Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer

Martin Peifer, Daniel Rauh, Gerhard Christofori, 2013 .

Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.

Roman K. Thomas, G. Christofori, M. Peifer, 2013, The Journal of clinical investigation.

Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping.

A. Ganser, F. Herrmann, R. Mertelsmann, 1988, Leukemia research.

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations

M. Schlaak, R. Büttner, H. Schildhaus, 2014, BMC Cancer.

Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer

U. Fuhr, F. Dietlein, B. Neumaier, 2015, Oncotarget.

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

H. Ji, Roman K. Thomas, W. Pao, 2016, Clinical Cancer Research.

Loss of the Keratin Cytoskeleton Is Not Sufficient to Induce Epithelial Mesenchymal Transition in a Novel KRAS Driven Sporadic Lung Cancer Mouse Model

E. Wardelmann, R. Buettner, T. Magin, 2013, PloS one.

Tuberous-sclerosis complex-related cell signaling in the pathogenesis of lung cancer

Reinhard Büttner, Sebastian Huss, Lukas C Heukamp, 2014, Diagnostic Pathology.

Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells

Jeffrey S. Hannam, M. Famulok, Anke Bill, 2012, PloS one.

Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient.

Roman K. Thomas, F. Leenders, J. Wolf, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy

C. Mamot, S. Aebi, R. Büttner, 2015, Oncology Research and Treatment.

Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice

F. Speleman, B. Menten, J. Vandesompele, 2012, Science Translational Medicine.

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

T. Zander, M. Odenthal, Y. Ko, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.